CDIB Capital is a leading Asia-based investment firm focused on delivering superior private equity returns. The firm specializes in Asian private equity, private debt, and special situations investments, strategically backing high-growth companies positioned to benefit from China's long-term secular growth. CDIB Capital typically invests in Series A and Series B rounds, with investments ranging from $12 million to $47 million.

As the overseas investment arm of China Development Financial, CDIB Capital partners with high-quality entrepreneurs and management teams to drive shareholder value in the Asia-Pacific region. The firm's portfolio includes notable companies such as Acepodia, Clobotics, and Kneron. CDIB Capital's team of investment professionals brings extensive industry expertise and deep local knowledge to support their portfolio companies' growth and expansion.